Discover HKBU

Advancing the development of smart Chinese medicine

20 Dec 2023

{{currentSlide}} / 2
The Agreement was signed by Professor Terence Lau, Interim Chief Innovation Officer of HKBU (left, front row), and Mr Zhi Zhe, Executive Vice Dean of CRRIST (right, front row). Mr Wang Weiming, Director General of Education and Technology Department in the Liaison Office of the Central People’s Government in the HKSAR (second right, back row); Ms Wu Cheng, Deputy Director General of Education and Technology Department in the Liaison Office of the Central People’s Government in the HKSAR (first left, back row); Ms Lillian Cheong, Under Secretary for Innovation, Technology and Industry (second left, back row); Professor Alexander Wai, President and Vice-Chancellor of HKBU (third left, back row); Mr Wang Xiangming, Chairman of China Resources Group (third right, back row); and Mr Chen Ying, Assistant President of China Resources Group, Chairman of CR Enterprise (first right, back row) witness the ceremony.
Professor Alexander Wai, President and Vice-Chancellor of HKBU (sixth left); Mr Wang Xiangming, Chairman of China Resources Group (fifth right) and other guests officiate at the plaque unveiling ceremony of the CR-BU Joint Innovation Centre on Smart Chinese Medicine.

HKBU and China Resources Research Institute of Science and Technology Co. Limited (CRRIST), a subsidiary of China Resources Enterprise Limited (CR Enterprise), jointly established the CR-BU Joint Innovation Centre on Smart Chinese Medicine to drive advancements in Chinese medicine and the development of an innovative Chronic Disease Management System.

The research and development collaboration agreement was signed on 19 December by Professor Terence Lau, Interim Chief Innovation Officer of HKBU, and Mr Zhi Zhe, Vice President of CR Enterprise, at the plaque unveiling ceremony of the CR-BU Joint Innovation Centre on Smart Chinese Medicine held on the HKBU campus.

At the ceremony, Professor Alexander Wai, President and Vice-Chancellor of HKBU, said: “The Central Government has placed a high emphasis on the advancement of Chinese medicine. The University’s research achievements demonstrate our contributions to promoting Hong Kong’s integration into the national development plan, inheritance and innovation of Chinese medicine, as well as expediting the standardisation and internationalisation of Chinese medicine. I believe the establishment of the CR-BU Joint Innovation Centre on Smart Chinese Medicine today marks a significant step for our collaborative efforts in propelling the development of Chinese medicine.”

Mr Wang Xiangming, Chairman of China Resources Group, said: “The establishment of the CR-BU Joint Innovation Centre on Smart Chinese Medicine is bound to further deepen the cooperation between the two parties in the development of smart Chinese medicine and its standardisation, and internationalisation. It will also further encourage the two parties to carry out a series of innovative research and application in chronic disease management, artificial intelligence and big data in Chinese medicine.”

The agreement lays the groundwork for closer collaboration between the two parties such as allocation of intellectual property, contributions and resources, with a detailed framework for promoting modernisation and scientific development of Chinese medicine.

Serving as a hub for cutting-edge research, innovation and collaboration in Chinese medicine, the Centre will launch an inaugural project to develop the innovative Chronic Disease Management System. The system will enable the comprehensive tracking of a patient’s medical journey, from diagnosis to treatment. It will also provide extended functions for follow-up medical care and long-term health management, which are vital for monitoring chronic disease.

Furthermore, researchers will benefit from the invaluable pool of tracked data provided by the system. This will serve as a solid foundation for research, including the analysis of overall treatment effectiveness and the identification of responses to Chinese medicine interventions.